Business2 sources

New pancreatic cancer drug halts tumor growth in 90% of patients

  • A new pancreatic cancer drug halted tumor growth in 90% of patients in a small-scale trial.
  • The successful trial has raised hopes that the new approach could be extended to other types of the disease.
  • The drug is hailed as the 'closest thing to a cure' and a 'biggest breakthrough in decades'.
  • The trial results have generated massive hope for a new treatment option for pancreatic cancer.
  • Further research and larger-scale trials are needed to confirm the drug's effectiveness and safety.
New pancreatic cancer drug halts tumor growth in 90% of patients | Split Angle